LifeQuest World Corp. (OTCID: LQWC) has filed its first quarterly report as a combined company, revealing a dramatic shift in scale following its June 12, 2026 acquisition of Compaction and Recycling Equipment, Inc. (CARE) and Columbia Financial Services, Inc. (CFSI). The unaudited results for the fiscal first quarter ended August 31, 2026, show revenue of $885,400 compared with no revenue in the same quarter of the prior year, and pretax income of $24,249 versus a net loss of $56,300 a year earlier—an $80,549 year-over-year improvement.
The filing, announced through NEWMEDIAWIRE, underscores a fundamental change in LifeQuest’s business. With CARE and CFSI now consolidated alongside BioPipe Global Corp., the company reported gross profit of $568,935, a gross margin of approximately 64%, and total assets of $2,125,492. Stockholders’ equity turned positive at $519,104, compared with a deficit of $(158,854) at fiscal year-end May 31, 2026, while working capital reached $397,302 and the current ratio improved to 1.25x from 0.85x.
“This filing is the first look at LifeQuest as the company we set out to build,” said Max Khan, President and Chief Executive Officer. “In a single quarter we moved from a development-stage wastewater technology company to a profitable environmental services platform with nearly $900,000 in quarterly revenue, more than $2.1 million in assets and positive stockholders’ equity.”
The strategic rationale behind the acquisitions is clear: CARE and CFSI provide a recurring revenue foundation in the Pacific Northwest through waste compaction, recycling equipment, and related financial services, while BioPipe continues to win international orders, including two recent containerized sewage treatment plants for labor camps in the United Arab Emirates. According to the company’s website at www.biopipe.co, BioPipe systems are chemical-free, produce zero sludge, and are virtually silent and odor-free, with approximately 52 plants installed across Europe, Africa, South Asia, Southeast Asia, and the Middle East.
The balance sheet also reflects improved liquidity, with cash and cash equivalents of $548,200, up from $187,320 at May 31, 2026, and $110,846 at August 31, 2025. Deferred revenue of $935,226 represents amounts billed or received in advance that the company expects to recognize as revenue in future periods as performance obligations are satisfied. Notably, the CARE and CFSI acquisition involved no cash paid at closing; it was completed for Series B Preferred Stock and an $85,000 promissory note. Interest-bearing obligations total just $100,000 in principal, with no long-term debt on the balance sheet.
LifeQuest has also relocated its headquarters from Ridgefield Park, New Jersey, to Clackamas, Oregon, positioning it closer to the acquired operations. The company’s roadmap includes completing a PCAOB-standard audit, filing a registration statement with the SEC (Form 10 or Form S-1), and applying for quotation on the OTCQB Venture Market. “Our priority now is completing a PCAOB audit and SEC registration so that investors can value LifeQuest on a fully reported basis,” Khan added.
For investors, the quarter represents a proof point that the combined entity can generate revenue and positive net income, a departure from its prior development-stage profile. However, the financial statements are unaudited and were not subject to an audit, review, or compilation, and the company cautions that the information may change upon completion of its audit and business combination accounting. More details are available in the original release at www.newmediawire.com.
